Question 1

Who are the latest insiders trading SAB Biotherapeutics, Inc. (SABS) stock?

Accepted Answer

The most recent insider trade for SAB Biotherapeutics, Inc. (SABS) was by Sessa Capital (Master), L.P. on July 22, 2025, who executed a purchase of 228,500 shares at $1.75 per share.

Question 2

How much SABS stock was sold by insiders this month?

Accepted Answer

There have been no insider sales recorded for SAB Biotherapeutics, Inc. (SABS) in the past 30 days. This could suggest insiders are holding their positions.

Question 3

Does SAB Biotherapeutics, Inc. show consistent insider selling or buying?

Accepted Answer

Over the last 12 months, insider activity at SAB Biotherapeutics, Inc. (SABS) shows a general trend of buying, with 0 sale transactions and 2 purchase transactions recorded.

Question 4

Are executives at SAB Biotherapeutics, Inc. actively trading their shares?

Accepted Answer

Yes, recent executive trades have been recorded. For example, Sessa Capital (Master), L.P. reported a purchase of 228,500 shares on 7/22/2025.

SAB Biotherapeutics, Inc.